MA05.07 Dose Escalated Chemo-RT to 84 Gy in Stage III NSCLC Appears Excessively Toxic: Results from a Randomized Phase II Trial

J. Nyman; S. Bergström; H. Björkestrand; A. Svärd; S. Ekman; E. Lundin; E. Holmberg; M. Johansson; S. Friesland; A. Hallqvist

doi:10.1016/j.jtho.2018.08.354

MA05.07 Dose Escalated Chemo-RT to 84 Gy in Stage III NSCLC Appears Excessively Toxic: Results from a Randomized Phase II Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.354 ◽

2018 ◽

Vol 13 (10) ◽

pp. S373

Author(s):

J. Nyman ◽

S. Bergström ◽

H. Björkestrand ◽

A. Svärd ◽

S. Ekman ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Stage Iii ◽

Randomized Phase Ii ◽

Stage Iii Nsclc

Download Full-text

Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: Mature results of the Spanish Lung Cancer Group 0008 study

Lung Cancer ◽

10.1016/j.lungcan.2013.03.009 ◽

2013 ◽

Vol 81 (1) ◽

pp. 84-90 ◽

Cited By ~ 18

Author(s):

Pilar Garrido ◽

Rafael Rosell ◽

Antonio Arellano ◽

Francisco Andreu ◽

Manuel Dómine ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Stage Iii ◽

Consolidation Chemotherapy ◽

Cancer Group ◽

Randomized Phase Ii ◽

Concomitant Chemoradiation ◽

Stage Iii Nsclc ◽

Nsclc Patients

Download Full-text

P2.02-027 A Randomized Phase II Trial of S-1 plus Cisplatin or Docetaxel plus Cisplatin with Concurrent Thoracic Radiotherapy for Stage III NSCLC: TORG1018

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.1174 ◽

2017 ◽

Vol 12 (1) ◽

pp. S863

Author(s):

Kazuhiko Yamada ◽

Tsuneo Shimokawa ◽

Hiroaki Okamoto ◽

Hiroshi Tanaka ◽

Kaoru Kubota ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Randomized Phase Ii ◽

Stage Iii Nsclc

Download Full-text

Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial

Lung Cancer ◽

10.1016/j.lungcan.2018.06.020 ◽

2018 ◽

Vol 122 ◽

pp. 180-186 ◽

Cited By ~ 8

Author(s):

Andreas Hallqvist ◽

Stefan Bergström ◽

Hedvig Björkestrand ◽

Anna-Maja Svärd ◽

Simon Ekman ◽

...

Keyword(s):

Phase Ii ◽

Dose Escalation ◽

Phase Ii Trial ◽

Concurrent Chemotherapy ◽

Stage Iii ◽

Randomized Phase Ii ◽

Stage Iii Nsclc

Download Full-text

RANDOMIZED PHASE II TRIAL OF CARBOPLATIN-PACLITAXEL COMPARED TO CARBOPLATIN-PACLITAXEL-TRASTUZUMAB IN ADVANCED (STAGE III-IV) OR RECURRENT UTERINE SEROUS CARCINOMA: RESULTS OF INTERIM ANALYSIS (NCT01367002)

10.26226/morressier.5770e29bd462b80290b4bae3 ◽

2016 ◽

Author(s):

Alessandro D Santin

Keyword(s):

Phase Ii ◽

Interim Analysis ◽

Phase Ii Trial ◽

Stage Iii ◽

Serous Carcinoma ◽

Advanced Stage ◽

Randomized Phase Ii ◽

Uterine Serous Carcinoma

Download Full-text

P-5 A phase II trial of paclitaxel carboplatin and gemcitabine as induction chemotherapy for stage III NSCLC

Lung Cancer ◽

10.1016/s0169-5002(03)91974-x ◽

2003 ◽

Vol 41 ◽

pp. S92

Author(s):

Carmelo Giannitto Giorgio ◽

Salvino Saita ◽

Franco Marletta ◽

Stefano Cordio ◽

Dario Giuffrida ◽

...

Keyword(s):

Induction Chemotherapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Stage Iii ◽

Stage Iii Nsclc

Download Full-text

OA01.07 Updated Results of a Phase II Trial of Concurrent Chemoradiation with Consolidation Pembrolizumab in Patients with Unresectable Stage III NSCLC

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.238 ◽

2018 ◽

Vol 13 (10) ◽

pp. S321 ◽

Cited By ~ 4

Author(s):

G. Durm ◽

S. Althouse ◽

A. Sadiq ◽

S. Jalal ◽

S. Jabbour ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Concurrent Chemoradiation ◽

Stage Iii ◽

Unresectable Stage ◽

Stage Iii Nsclc

Download Full-text

Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience

Breast Cancer Research and Treatment ◽

10.1007/s10549-013-2806-5 ◽

2013 ◽

Vol 143 (2) ◽

pp. 313-323 ◽

Cited By ~ 6

Author(s):

José Pablo Leone ◽

Julieta Leone ◽

Carlos Teodoro Vallejo ◽

Juan Eduardo Pérez ◽

Alberto Omar Romero ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Stage Iii ◽

Randomized Phase Ii ◽

Stage Iii Breast Cancer

Download Full-text

P382 A randomized phase II trial of sequential gemcitabine plusvinorelbine followed by gemcitabine plus Ifosfamide versus gemcitabine plus cisplatin in the treatment of chemonaïve patients with stage III and IV non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(05)81075-x ◽

2005 ◽

Vol 49 ◽

pp. S271

Author(s):

G. Teodorescu ◽

T. Ciuleanu ◽

A. Grigorescu ◽

E. Firoiu ◽

D. Ruta Muresan

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-20-0953 ◽

2020 ◽

Vol 26 (15) ◽

pp. 3928-3935 ◽

Cited By ~ 3

Author(s):

Amanda N. Fader ◽

Dana M. Roque ◽

Eric Siegel ◽

Natalia Buza ◽

Pei Hui ◽

...

Keyword(s):

Overall Survival ◽

Survival Analysis ◽

Phase Ii ◽

Phase Ii Trial ◽

Stage Iii ◽

Advanced Stage ◽

Randomized Phase Ii ◽

Overall Survival Analysis

Download Full-text

P3.17-12 Phase II Trial of Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC (AFT-16): Trial in Progress

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1968 ◽

2018 ◽

Vol 13 (10) ◽

pp. S1025

Author(s):

H. Ross ◽

D. Kozono ◽

J. Urbanic ◽

T. Williams ◽

C. Dufrane ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Stage Iii ◽

Unresectable Stage ◽

Before And After ◽

Stage Iii Nsclc

Download Full-text